1. Home
  2. IQV vs VEEV Comparison

IQV vs VEEV Comparison

Compare IQV & VEEV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IQV
  • VEEV
  • Stock Information
  • Founded
  • IQV 1982
  • VEEV 2007
  • Country
  • IQV United States
  • VEEV United States
  • Employees
  • IQV N/A
  • VEEV N/A
  • Industry
  • IQV Biotechnology: Commercial Physical & Biological Resarch
  • VEEV Computer Software: Prepackaged Software
  • Sector
  • IQV Health Care
  • VEEV Technology
  • Exchange
  • IQV Nasdaq
  • VEEV Nasdaq
  • Market Cap
  • IQV 35.7B
  • VEEV 37.4B
  • IPO Year
  • IQV 2013
  • VEEV 2013
  • Fundamental
  • Price
  • IQV $190.98
  • VEEV $225.74
  • Analyst Decision
  • IQV Strong Buy
  • VEEV Buy
  • Analyst Count
  • IQV 17
  • VEEV 27
  • Target Price
  • IQV $251.00
  • VEEV $253.15
  • AVG Volume (30 Days)
  • IQV 1.4M
  • VEEV 845.1K
  • Earning Date
  • IQV 02-06-2025
  • VEEV 03-05-2025
  • Dividend Yield
  • IQV N/A
  • VEEV N/A
  • EPS Growth
  • IQV 2.74
  • VEEV 16.44
  • EPS
  • IQV 7.49
  • VEEV 4.05
  • Revenue
  • IQV $15,405,000,000.00
  • VEEV $2,656,351,000.00
  • Revenue This Year
  • IQV $5.17
  • VEEV $17.95
  • Revenue Next Year
  • IQV $6.04
  • VEEV $12.20
  • P/E Ratio
  • IQV $25.51
  • VEEV $55.73
  • Revenue Growth
  • IQV 2.81
  • VEEV 15.67
  • 52 Week Low
  • IQV $187.62
  • VEEV $170.25
  • 52 Week High
  • IQV $261.73
  • VEEV $258.93
  • Technical
  • Relative Strength Index (RSI)
  • IQV 37.76
  • VEEV 43.52
  • Support Level
  • IQV $192.10
  • VEEV $229.19
  • Resistance Level
  • IQV $198.90
  • VEEV $235.59
  • Average True Range (ATR)
  • IQV 5.43
  • VEEV 5.01
  • MACD
  • IQV -1.28
  • VEEV -1.42
  • Stochastic Oscillator
  • IQV 0.75
  • VEEV 3.70

About IQV IQVIA Holdings Inc.

IQVIA is the result of the 2016 merger of Quintiles, a leading global contract research organization, and IMS Health, a leading healthcare data and analytics provider. The research and development segment focuses primarily on providing outsourced late-stage clinical trials for pharmaceutical, device, and diagnostic firms. The technology and analytics segment provides aggregated information and technology services to clients in the healthcare industry, including pharmaceutical companies, providers, payers, and policymakers, as well as data and analytics capabilities for clinical trials, including virtual trials. The company also has a small contract sales business.

About VEEV Veeva Systems Inc.

Veeva is the global leading supplier of cloud-based software solutions for the life sciences industry. The company's best-of-breed offerings address operating and regulatory requirements for customers ranging from small, emerging biotechnology companies to departments of global pharmaceutical manufacturers. The company leverages its domain expertise to improve the efficiency and compliance of the underserved life sciences industry, displacing large, highly customized and dated enterprise resource planning systems that have limited flexibility. Its two main products are Veeva CRM, a customer relationship management platform for companies with a salesforce, and Veeva Vault, a content management platform that tackles various functions within any life sciences company.

Share on Social Networks: